Bendell, Johanna C.

P-71 KRYSTAL-10: A randomized phase 3 study of adagrasib (MRTX849) in combination with cetuximab vs chemotherapy in patients with previously treated advanced colorectal cancer with KRASG12C mutation

Tabernero, J., Bendell, J., Corcoran, R., Kopetz, S., Lee, J., Davis, M., Christensen, J., Chi, A., Kheoh, T., & Yaeger, R. (2021) · Annals of Oncology

Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations

Cited by 28

P-325 Oral delivery of a single microbial strain, EDP1503, induces anti-tumor responses via gut-mediated activation of both innate and adaptive immunity

McHale, D., Francisco-Anderson, L., Sandy, P., Shariffudin, S., Goldberg, M., Gardner, H., Abdou, M., Kashyap, S., Argueta, S., Parameswaran, P., et al. (2020) · Annals of Oncology

Probiotics and Fermented FoodsBacterial Cancer Therapy

Cited by 18

Phase 3, open-label, randomized study of first-line pembrolizumab (pembro) vs. investigator-choice chemotherapy for mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal carcinoma (mCRC): KEYNOTE-177

Diaz, L. A., Le, D. T., Yoshino, T., Andre, T., Bendell, J. C., Koshiji, M., Zhang, Y., Kang, S. P., Lam, B., & Jaeger, D. (2017) · Journal of Clinical Oncology

Colorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers

Cited by 11

LBA-01 safety and efficacy of cobimetinib (cobi) and atezolizumab (atezo) in a Phase 1b study of metastatic colorectal cancer (mCRC)

Bendell, J., Tae Won, K., Cheng Ean, C., Yung-Jue, B., Lee, C., Desai, J., Lewin, J., Wallin, J., Das Thakur, M., Mwawasi, G., et al. (2016) · Annals of Oncology

Colorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers

Cited by 9